3-((2R,5R)-5-ETHYL-7-OXO-1,2,5,7-TETRAHYDRO-4H-FURO(3,4-D)(1,3)THIAZIN-2-YL)-6-(4-HYDROXYPHENYL)PIPERAZINE-2,5-DIONE
UNII 8N83758583
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-((2r,5r)-5-ethyl-7-oxo-1,2,5,7-tetrahydro-4h-furo(3,4-d)(1,3)thiazin-2-yl)-6-(4-hydroxyphenyl)piperazine-2,5-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8N83758583.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H19N3O5S HBCLZRKQUWQQOQ-NQLFFAADSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-((2r,5r)-5-ethyl-7-oxo-1,2,5,7-tetrahydro-4h-furo(3,4-d)(1,3)thiazin-2-yl)-6-(4-hydroxyphenyl)piperazine-2,5-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.